When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach
Primary antibody deficiencies (PAD) constitute the majority of all primary immunodeficiency diseases (PID) and immunoglobulin replacement forms the mainstay of therapy for many patients in this category. Secondary antibody deficiencies (SAD) represent a larger and expanding number of patients result...
Main Authors: | Jolles, S, Chapel, H, Litzman, J |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley
2016
|
Similar Items
-
Should treatment of hypogammaglobulinemia with immunoglobulin replacement therapy (IgRT) become standard of care in patients with chronic lymphocytic leukemia?
by: Alessandro Noto, et al.
Published: (2023-04-01) -
Immunoglobulin replacement therapy for primary immunodeficiencies.
by: Peter, J, et al.
Published: (2014) -
Subcutaneous immunoglobulin replacement therapy: the European experience.
by: Chapel, H, et al.
Published: (2013) -
Antibody deficiency secondary to chronic lymphocytic leukemia: Should patients be treated with prophylactic replacement immunoglobulin?
by: Dhalla, F, et al.
Published: (2014) -
Antibody deficiency secondary to chronic lymphocytic leukemia: Should patients be treated with prophylactic replacement immunoglobulin?
by: Dhalla, F, et al.
Published: (2014)